Pathik Gandotra of Dron Capital feels Ranbaxy Labs can also give a very high return, but it is extremely risky, he adds.
first published: Oct 5, 2013 03:24 pm
A collection of the most-viewed Moneycontrol videos.

Live: Can Nifty claim new lifetime highs in December series? | Opening Bell

Live: Sensex, Nifty rangebound on monthly expiry day | Closing Bell

Live: Will Nifty's downtrend continue to third session on expiry day? | Opening Bell

Nifty Slips Below 26,100 Amid Sluggish Trade, Midcaps Struggle; IT Lends Support | Closing Bell Live
You are already a Moneycontrol Pro user.

